3 unchanged sentences
Exhibit Number Description
−Removed: Pacira BioSciences, Inc.
−Removed: Deferred Compensation Plan.(1)†
+Added: Indenture, dated as of July 10, 2020, by and between the Company and Wells Fargo Bank, National Association.(1)
+Added: Form of Global 0.750% Convertible Senior Note due 2025.(1)
Certification of Chief Executive Officer and Chairman pursuant to Rule 13a-14(a) and 15d-14(a), as amended.*
3 unchanged sentences
101 The following materials from the Quarterly Report on Form 10-Q of Pacira BioSciences, Inc.
−Removed: for the quarter ended June 30, 2020, formatted in iXBRL (Inline eXtensible Business Reporting Language):
+Added: for the quarter ended September 30, 2020, formatted in iXBRL (Inline eXtensible Business Reporting Language):
(i) the Condensed Consolidated Balance Sheets;
7 unchanged sentences
** Furnished herewith.
−Removed: † Denotes management contract or compensatory plan or arrangement
−Removed: (1) Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed on June 11, 2020.
+Added: (1) Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on July 10, 2020
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
PACIRA BIOSCIENCES, INC.
−Removed: August 6, 2020 /s/ DAVID STACK
+Added: October 29, 2020 /s/ DAVID STACK
Chief Executive Officer and Chairman
(Principal Executive Officer)
−Removed: August 6, 2020 /s/ CHARLES A.
+Added: October 29, 2020 /s/ CHARLES A.
REINHART, III
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.